– The randomized controlled trials were marked by a high risk of bias, largely due to flawed analysis methods and inadequate monitoring of adverse events. The most consistent finding across reviews was that continuing esketamine beyond the 4-week induction phase
This is Aalto. A Professional theme for
architects, construction and interior designers